Literature DB >> 20729719

Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice.

Jessica A Siegel1, Michael J Craytor, Jacob Raber.   

Abstract

Exposure to methamphetamine during brain development impairs cognition in humans and rodents. In mice, these impairments are more severe in females than males. Genetic factors, such as apolipoprotein E genotype, may modulate the cognitive effects of methamphetamine. Methamphetamine-induced alterations in the brain acetylcholine system may contribute to the cognitive effects of methamphetamine and may also be modulated by apolipoprotein E isoform. We assessed the long-term effects of methamphetamine exposure during brain development on cognitive function and muscarinic acetylcholine receptors in mice, and whether apolipoprotein E isoform modulates these effects. Mice expressing human apolipoprotein E3 or E4 were exposed to methamphetamine (5 mg/kg) or saline once a day from postnatal days 11-20 and behaviorally tested in adulthood. Muscarinic acetylcholine receptor binding was measured in the hippocampus and cortex. Methamphetamine exposure impaired novel location recognition in female, but not male, mice. Methamphetamine-exposed male and female mice showed impaired novel object recognition and increased number of muscarinic acetylcholine receptors in the hippocampus. The cognitive and cholinergic effects of methamphetamine were similar in apolipoprotein E3 and E4 mice. Thus, the cholinergic system, but not apolipoprotein E isoform, might play an important role in the long-term methamphetamine-induced cognitive deficits in adulthood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729719      PMCID: PMC2990349          DOI: 10.1097/FBP.0b013e32833e7e44

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  104 in total

1.  Regional frontal injuries cause distinct impairments in cognitive control.

Authors:  M P Alexander; D T Stuss; T Picton; T Shallice; S Gillingham
Journal:  Neurology       Date:  2007-05-01       Impact factor: 9.910

2.  Characteristics of object location memory in mice: Behavioral and pharmacological studies.

Authors:  Takeshi Murai; Shoki Okuda; Takeshi Tanaka; Hisashi Ohta
Journal:  Physiol Behav       Date:  2006-10-16

3.  Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.

Authors:  P M Sullivan; H Mezdour; Y Aratani; C Knouff; J Najib; R L Reddick; S H Quarfordt; N Maeda
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

4.  Apolipoprotein E gene polymorphism and previous alcohol withdrawal seizures.

Authors:  Julia Wilhelm; Nicolas von Ahsen; Thomas Hillemacher; Kristina Bayerlein; Helge Frieling; Johannes Kornhuber; Stefan Bleich
Journal:  J Psychiatr Res       Date:  2006-09-07       Impact factor: 4.791

5.  Sex- and histamine-dependent long-term cognitive effects of methamphetamine exposure.

Authors:  Summer F Acevedo; Iwan J P de Esch; Jacob Raber
Journal:  Neuropsychopharmacology       Date:  2006-05-10       Impact factor: 7.853

6.  Impairments in spatial memory retention of GFAP-apoE4 female mice.

Authors:  Peter van Meer; Summer Acevedo; Jacob Raber
Journal:  Behav Brain Res       Date:  2006-11-28       Impact factor: 3.332

7.  Age-dependent effects of neonatal methamphetamine exposure on spatial learning.

Authors:  Charles V Vorhees; Matthew R Skelton; Michael T Williams
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

8.  Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation.

Authors:  Sara Garcia-Ratés; Jordi Camarasa; Elena Escubedo; David Pubill
Journal:  Toxicol Appl Pharmacol       Date:  2007-05-26       Impact factor: 4.219

9.  Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits.

Authors:  Matthew R Skelton; Michael T Williams; Tori L Schaefer; Charles V Vorhees
Journal:  Psychoneuroendocrinology       Date:  2007-07-02       Impact factor: 4.905

10.  Web-based method for translating neurodevelopment from laboratory species to humans.

Authors:  Barbara Clancy; Brandon Kersh; James Hyde; Richard B Darlington; K J S Anand; Barbara L Finlay
Journal:  Neuroinformatics       Date:  2007
View more
  17 in total

1.  Long-term effects of early adolescent methamphetamine exposure on depression-like behavior and the hypothalamic vasopressin system in mice.

Authors:  Lauren Joca; Damian G Zuloaga; Jacob Raber; Jessica A Siegel
Journal:  Dev Neurosci       Date:  2014-03-27       Impact factor: 2.984

2.  Effects of adolescent methamphetamine and nicotine exposure on behavioral performance and MAP-2 immunoreactivity in the nucleus accumbens of adolescent mice.

Authors:  Jordan M Buck; Alysse S Morris; Sydney J Weber; Jacob Raber; Jessica A Siegel
Journal:  Behav Brain Res       Date:  2017-01-12       Impact factor: 3.332

3.  Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Authors:  Devon L Graham; Robyn M Amos-Kroohs; Amanda A Braun; Curtis E Grace; Tori L Schaefer; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 5.176

4.  Long-term effects of neonatal methamphetamine exposure on cognitive function in adolescent mice.

Authors:  Jessica A Siegel; Byung S Park; Jacob Raber
Journal:  Behav Brain Res       Date:  2011-01-14       Impact factor: 3.332

5.  Methamphetamine exposure during brain development alters the brain acetylcholine system in adolescent mice.

Authors:  Jessica A Siegel; Byung S Park; Jacob Raber
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

6.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

7.  Structural brain changes in prenatal methamphetamine-exposed children.

Authors:  Annerine Roos; Gaby Jones; Fleur M Howells; Dan J Stein; Kirsten A Donald
Journal:  Metab Brain Dis       Date:  2014-02-20       Impact factor: 3.584

8.  Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.

Authors:  Ingrid Reverte; Fiona Peris-Sampedro; Pia Basaure; Leticia Campa; Cristina Suñol; Margarita Moreno; José Luis Domingo; Maria Teresa Colomina
Journal:  Psychopharmacology (Berl)       Date:  2016-01       Impact factor: 4.530

Review 9.  Chronic methamphetamine self-administration disrupts cortical control of cognition.

Authors:  Aurelien Bernheim; Ronald E See; Carmela M Reichel
Journal:  Neurosci Biobehav Rev       Date:  2016-07-20       Impact factor: 8.989

10.  Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins.

Authors:  Damian G Zuloaga; Jessica A Siegel; Summer F Acevedo; Maayan Agam; Jacob Raber
Journal:  Dev Neurosci       Date:  2013-07-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.